Bischoff+Scheck AG, the special-vehicle manufacturer, together with the Fraunhofer Institute for Biomedical Engineering (IBMT) has developed a mobile test laboratory, the "MobiLab", to carry out COVID-19 tests, antibody tests and vaccinations. The intention is to use the "MobiLab" to test for COVID-19 at companies, public authorities, professional sports clubs and hospitals among other places, and to carry out mass tests. The laboratory fulfils all the necessary technical and medical requirements including personnel, to test up to 400 people per day for antibodies and to perform swab/PCR tests. In the event of a positive antibody test result indicating an acute infection, a swab can be immediately taken from the person in question and a clarifying PCR test performed in the laboratory. The results of the antibody test are available in just a few minutes, and the results of the PCR diagnostics – used to detect the pathogens – are available within a few hours. By using the "MobiLab", medical resources that were partially withdrawn from the health-care system during the pandemic can be returned to their intended use and tasks. The "MobiLab" will be available from mid-August 2020 and can be rented, leased or purchased. The Corona App can only be supplied with information when sufficient testing has been carried out to obtain results.

This type of mobile testing for the first time offers the possibility of testing larger groups of people on company or public-authority premises and obtaining the results shortly afterwards, thereby providing certainty as to whether anyone has been infected, and if so, who is infected, who is not infected and who is acutely infected. The tests are intended to prevent individual work absences through to complete production stoppages, and to provide the certainty that no infected employees are working. The intention is also to identify infected persons/groups of persons at an early stage. The fact that samples are taken under the same medical, spatial and technical conditions means that the results are comparable.

The laboratories are to be used not only for vaccinations and blood sampling, but also for major events and disaster-relief operations where laboratory capacity and treatment rooms are needed quickly, and can be technically upgraded to security level S3 in order to test for "undefined pathogens" such as viruses, bacteria, fungi and parasites.

Über die Bischoff + Scheck AG

Bischoff + Scheck AG from Rheinmünster has stood for intelligent concepts in special-vehicle construction since the company was founded in 1997. In close cooperation with its customers, the Baden-based company realises tailor-made high-performance vehicles for all conceivable tasks – from the initial idea right through to the finished vehicle, including complete servicing. All the development and production stages take place under one roof at Baden-Airpark in Rheinmünster, with all the departments perfectly coordinated for every project. From racing trailers for the safe transport of high-tech motor-sport vehicles, horse transporters and promotional and technology vehicles, through to motor homes, event vehicles and mobile test laboratories, Bischoff+Scheck offers its customers a range of innovative solutions.

Firmenkontakt und Herausgeber der Meldung:

Bischoff + Scheck AG
Victoria Boulevard D 100
77836 Rheinmünster Baden Airpark
Telefon: +49 (7229) 18680-0
Telefax: +49 (7229) 18680-68
http://www.bischoff-scheck.de

Ansprechpartner:
Bernd Bischoff
Management board
Telefon: 0049 7229 18680-40
E-Mail: bernd.bischoff@bischoff-scheck.de
Für die oben stehende Pressemitteilung ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.

counterpixel